ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Ophthalmology

Top Ophthalmology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERTO BERAJA MD

Ophthalmology

38,133

$4.51M

4863
4347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 60%

$118
Average prescription price

Avg: $75

ANDRES CORTES MD

Ophthalmology

25,484

$1.85M

3704
3564 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $75

YASAMAN MOHADJER MD

Ophthalmology

16,555

$1.03M

818
584 are 65+

20%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 60%

$62
Average prescription price

Avg: $75

ARNULFO MANSUR M.D.

Ophthalmology

14,428

$2.2M

3502
3319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

89%
prescriptions for brand name drugs

Avg: 60%

$152
Average prescription price

Avg: $75

JOHN BENEKE MD

Ophthalmology

13,722

$836K

1882
1669 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 60%

$61
Average prescription price

Avg: $75

MANUEL AIRALA MD

Ophthalmology

13,644

$1M

2465
2330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $75

OSWALD RONDON M.D.

Ophthalmology

13,151

$1.12M

2867
2715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

76%
prescriptions for brand name drugs

Avg: 60%

$85
Average prescription price

Avg: $75

MAX CORNDORF M.D.

Ophthalmology

13,134

$831K

2789
2670 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 60%

$63
Average prescription price

Avg: $75

ERIC GECHTER MD

Ophthalmology

12,417

$713K

2304
2173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 60%

$57
Average prescription price

Avg: $75

KARIM SAMARA MD

Ophthalmology

10,828

$579K

145
135 are 65+

20%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 60%

$53
Average prescription price

Avg: $75

CLINTON SHEETS M.D.

Ophthalmology

10,763

$591K

2156
2010 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

52%
prescriptions for brand name drugs

Avg: 60%

$55
Average prescription price

Avg: $75

GABRIEL LAZCANO M.D.

Ophthalmology

10,677

$799K

2384
2253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 60%

$75
Average prescription price

Avg: $75

TOMMY COFFMAN MD

Ophthalmology

10,030

$499K

2143
2054 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

56%
prescriptions for brand name drugs

Avg: 60%

$50
Average prescription price

Avg: $75

MARCO FABREGA M.D.

Ophthalmology

9,911

$695K

2414
2266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $75

LOURDES CASUSO M.D.

Ophthalmology

9,828

$776K

869
802 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$79
Average prescription price

Avg: $75

HECTOR LAURENCIO M.D.

Ophthalmology

9,554

$709K

1184
1133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 60%

$74
Average prescription price

Avg: $75

HARRY PAPPAS M.D.

Ophthalmology

9,436

$522K

1483
1377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

59%
prescriptions for brand name drugs

Avg: 60%

$55
Average prescription price

Avg: $75

ANTONIO PRADO M.D.

Ophthalmology

9,358

$636K

2158
1962 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 60%

$68
Average prescription price

Avg: $75

GEETA SHAH M.D.

Ophthalmology

9,219

$405K

1731
1575 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 60%

$44
Average prescription price

Avg: $75

ALEXEI MORACZEWSKI MD

Ophthalmology

9,149

$586K

1229
1055 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $75

NORMA BARTON MD PHD

Ophthalmology

8,678

$502K

988
966 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 60%

$58
Average prescription price

Avg: $75

MORTON KURSTIN M.D.

Ophthalmology

8,398

$691K

1179
1075 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 60%

$82
Average prescription price

Avg: $75

ALAN SILBERT MD

Ophthalmology

8,393

$454K

1546
1439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

62%
prescriptions for brand name drugs

Avg: 60%

$54
Average prescription price

Avg: $75

HERBERT KNAUF MD

Ophthalmology

8,311

$499K

1916
1788 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 60%

$60
Average prescription price

Avg: $75

CARLOS BUZNEGO M.D.

Ophthalmology

8,242

$639K

1348
1300 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

73%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $75

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank